Stanniocalcin 1 is important for poststroke functionality, but dispensable for ischemic tolerance

Neuroscience

Volumn 229, Issue , 2013, Pages 49-54

  Durukan Tolvanen, A ^a,b   Westberg, J A ^c   Serlachius, M ^c   Chang, A C M ^d,e   Reddel, R R ^d,e   Andersson, L C ^c   Tatlisumak, T ^a,b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b Biomedicum Helsinki   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d CHILDREN'S MEDICAL RESEARCH INSTITUTE   (Australia)

^e UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Brain ischemia; Hypoxia; IL 6; Mouse; Preconditioning; Stanniocalcin

Indexed keywords

HYPOCALCIN; MESSENGER RNA; STANNIOCALCIN 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; BRAIN LEVEL; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; GENE; GENE EXPRESSION; IL 6 GENE; ISCHEMIA TOLERANCE; ISCHEMIC PRECONDITIONING; MOUSE; NEUROLOGICAL SCORE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SCORING SYSTEM; STC1 GENE; STC2 GENE; STRAIN DIFFERENCE; UPREGULATION; WILD TYPE;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; BRAIN ISCHEMIA; GLYCOPROTEINS; INFARCTION, MIDDLE CEREBRAL ARTERY; INTERLEUKIN-6; ISCHEMIC PRECONDITIONING; MICE; MICE, KNOCKOUT; PERMEABILITY; RECOVERY OF FUNCTION; RNA, MESSENGER;

EID: 84870852379     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2012.10.062     Document Type: Article

References (29)

1. Abramoff M.D., Magalhaes P.J., Ram S.J. Image processing with Imaje J. Biophotonics Int 2004, 11:36-42.
2. Bernaudin M., Nedelec A.S., Divoux D., MacKenzie E.T., Petit E., Schumann-Bard P. Normobaric hypoxia induces tolerance to focal permanent cerebral ischemia in association with an increased expression of hypoxia-inducible factor-1 and its target genes, erythropoietin and VEGF, in the adult mouse brain. J Cereb Blood Flow Metab 2002, 22:393-403.
3. Byun J.S., Lee J.W., Kim S.Y., Kwon K.J., Sohn J.H., Lee K., Oh D., Kim S.S., Chun W., Lee H.J. Neuroprotective effects of stanniocalcin 2 following kainic acid-induced hippocampal degeneration in ICR mice. Peptides 2010, 31:2094-2099.
4. Chang A.C., Cha J., Koentgen F., Reddel R.R. The murine stanniocalcin 1 gene is not essential for growth and development. Mol Cell Biol 2005, 25:10604-10610.
5. Chang A.C., Janosi J., Hulsbeek M., de Jong D., Jeffrey K.J., Noble J.R., Reddel R.R. A novel human cDNA highly homologous to the fish hormone stanniocalcin. Mol Cell Endocrinol 1995, 112:241-247.
6. Chang A.C., Reddel R.R. Identification of a second stanniocalcin cDNA in mouse and human: stanniocalcin 2. Mol Cell Endocrinol 1998, 141:95-99.
7. Franzen A.M., Zhang K.Z., Westberg J.A., Zhang W.M., Arola J., Olsen H.S., Andersson L.C. Expression of stanniocalcin in the epithelium of human choroid plexus. Brain Res 2000, 887:440-443.
8. Hull K., Marler R., Harvey S. Neural calcitropic peptides: immunoreactive characterization in fish and invertebrates. Neurosci Lett 2006, 404:15-19.
9. Ito D., Walker J.R., Thompson C.S., Moroz I., Lin W., Veselits M.L., Hakim A.M., Fienberg A.A., Thinakaran G. Characterization of stanniocalcin 2, a novel target of the mammalian unfolded protein response with cytoprotective properties. Mol Cell Biol 2004, 24:9456-9469.
10. Jung J.E., Kim G.S., Chan P.H. Neuroprotection by interleukin-6 is mediated by signal transducer and activator of transcription 3 and antioxidative signaling in ischemic stroke. Stroke 2011, 42:3574-3579.
11. Law A.Y., Wong C.K. Stanniocalcin-2 is a HIF-1 target gene that promotes cell proliferation in hypoxia. Exp Cell Res 2010, 316:466-476.
12. Li Y.W., Jin H.L., Wang B.G., Shi Z.H., Li J. Toll-like receptor 4 signal pathway may be involved in cerebral ischemic tolerance induced by hypoxic preconditioning: experiment with rats. Zhonghua Yi Xue Za Zhi 2007, 87:2458-2462.
13. Liu Z., Qiu Y.H., Li B., Ma S.H., Peng Y.P. Neuroprotection of interleukin-6 against NMDA-induced apoptosis and its signal-transduction mechanisms. Neurotox Res 2011, 19:484-495.
14. Long Y., Zou L., Liu H., Lu H., Yuan X., Robertson C.S., Yang K. Altered expression of randomly selected genes in mouse hippocampus after traumatic brain injury. J Neurosci Res 2003, 71:710-720.
15. Longa E.Z., Weinstein P.R., Carlson S., Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989, 20:84-91.
16. Manalo D.J., Rowan A., Lavoie T., Natarajan L., Kelly B.D., Ye S.Q., Garcia J.G., Semenza G.L. Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood 2005, 105:659-669.
17. Menzies S.A., Hoff J.T., Betz A.L. Middle cerebral artery occlusion in rats: a neurological and pathological evaluation of a reproducible model. Neurosurgery 1992, 31:100-106.
18. Pedrono E., Durukan A., Strbian D., Marinkovic I., Shekhar S., Pitkonen M., Abo-Ramadan U., Tatlisumak T. An optimized mouse model for transient ischemic attack. J Neuropathol Exp Neurol 2010, 69:188-195.
19. Ratkovic S., Wagner G.F., Ciriello J. Distribution of stanniocalcin binding sites in the lamina terminalis of the rat. Brain Res 2008, 1218:141-150.
20. Strbian D., Durukan A., Pitkonen M., Marinkovic I., Tatlisumak E., Pedrono E., Abo-Ramadan U., Tatlisumak T. The blood-brain barrier is continuously open for several weeks following transient focal cerebral ischemia. Neuroscience 2008, 153:175-181.
21. Tatlisumak T., Carano R.A., Takano K., Opgenorth T.J., Sotak C.H., Fisher M. A novel endothelin antagonist, A-127722, attenuates ischemic lesion size in rats with temporary middle cerebral artery occlusion: a diffusion and perfusion MRI study. Stroke 1998, 29:850-857.
22. Tatlisumak T., Takano K., Carano R.A., Miller L.P., Foster A.C., Fisher M. Delayed treatment with an adenosine kinase inhibitor, GP683, attenuates infarct size in rats with temporary middle cerebral artery occlusion. Stroke 1998, 29:1952-1958.
23. Varghese R., Wong C.K., Deol H., Wagner G.F., DiMattia G.E. Comparative analysis of mammalian stanniocalcin genes. Endocrinology 1998, 139:4714-4725.
24. Wagner G.F., Hampong M., Park C.M., Copp D.H. Purification, characterization, and bioassay of teleocalcin, a glycoprotein from salmon corpuscles of Stannius. Gen Comp Endocrinol 1986, 63:481-491.
25. Westberg J.A., Serlachius M., Lankila P., Penkowa M., Hidalgo J., Andersson L.C. Hypoxic preconditioning induces neuroprotective stanniocalcin-1 in brain via IL-6 signaling. Stroke 2007, 38:1025-1030.
26. Yeung H.Y., Lai K.P., Chan H.Y., Mak N.K., Wagner G.F., Wong C.K. Hypoxia-inducible factor-1-mediated activation of stanniocalcin-1 in human cancer cells. Endocrinology 2005, 146:4951-4960.
27. Yoshiko Y., Aubin J.E. Stanniocalcin 1 as a pleiotropic factor in mammals. Peptides 2004, 25:1663-1669.
28. Zhang K., Lindsberg P.J., Tatlisumak T., Kaste M., Olsen H.S., Andersson L.C. Stanniocalcin: a molecular guard of neurons during cerebral ischemia. Proc Natl Acad Sci U S A 2000, 97:3637-3642.
29. Zhang K.Z., Westberg J.A., Paetau A., von Boguslawsky K., Lindsberg P., Erlander M., Guo H., Su J., Olsen H.S., Andersson L.C. High expression of stanniocalcin in differentiated brain neurons. Am J Pathol 1998, 153:439-445.